LifeStance Health Group, Inc.
LFST
$5.87
$0.020.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.25B | 1.21B | 1.16B | 1.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.28B | 1.25B | 1.21B | 1.16B | 1.10B |
| Cost of Revenue | 866.04M | 848.57M | 829.82M | 804.21M | 776.29M |
| Gross Profit | 417.46M | 402.40M | 376.28M | 352.06M | 327.22M |
| SG&A Expenses | 367.42M | 361.17M | 351.93M | 350.34M | 351.37M |
| Depreciation & Amortization | 62.14M | 70.95M | 78.50M | 83.00M | 83.93M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30B | 1.28B | 1.26B | 1.24B | 1.21B |
| Operating Income | -12.10M | -29.72M | -54.15M | -81.29M | -108.09M |
| Income Before Tax | -38.35M | -57.61M | -87.05M | -159.64M | -189.04M |
| Income Tax Expenses | -2.71M | -170.00K | 8.24M | -8.72M | -15.92M |
| Earnings from Continuing Operations | -35.64 | -57.44 | -95.29 | -150.92 | -173.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.64M | -57.44M | -95.29M | -150.92M | -173.12M |
| EBIT | -12.10M | -29.72M | -54.15M | -81.29M | -108.09M |
| EBITDA | 50.05M | 41.23M | 24.35M | 1.71M | -24.15M |
| EPS Basic | -0.09 | -0.15 | -0.26 | -0.41 | -0.47 |
| Normalized Basic EPS | -0.06 | -0.09 | -0.13 | -0.17 | -0.22 |
| EPS Diluted | -0.09 | -0.16 | -0.26 | -0.41 | -0.47 |
| Normalized Diluted EPS | -0.06 | -0.09 | -0.13 | -0.17 | -0.22 |
| Average Basic Shares Outstanding | 1.52B | 1.52B | 1.50B | 1.50B | 1.48B |
| Average Diluted Shares Outstanding | 1.53B | 1.52B | 1.50B | 1.50B | 1.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |